Winton Group’s Tenet Healthcare THC Stock Holding History

Winton Group’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$730K	Buy	3,900 +2,200	+129%	+$404K	0.02%	587
2026 Q1	$321K	Buy	+1,700	New	+$358K	0.01%	842
2025 Q4	–	Sell	-38,161	Closed	-$7.75M	–	1107
2025 Q3	$7.75M	Buy	+38,161	New	+$6.77M	0.29%	83
2024 Q4	–	Sell	-42,473	Closed	-$7.06M	–	783
2024 Q3	$7.06M	Buy	+42,473	New	+$6.42M	0.49%	33
2024 Q2	–	Sell	-29,555	Closed	-$3.11M	–	733
2024 Q1	$3.11M	Buy	+29,555	New	+$2.66M	0.22%	86
2023 Q3	–	Sell	-42,530	Closed	-$3.46M	–	929
2023 Q2	$3.46M	Buy	42,530 +38,029	+845%	+$2.71M	0.29%	70
2023 Q1	$267K	Sell	4,501 -101,438	-96%	-$5.64M	0.02%	849
2022 Q4	$5.17M	Buy	+105,939	New	+$4.9M	0.34%	31
2017 Q1	–	Sell	-26,843	Closed	-$398K	–	491
2016 Q4	$398K	Buy	+26,843	New	+$482K	0.01%	386

Other funds holding THC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Winton Group's THC Position: Q2 2026 in Review

Winton Group increased its Tenet Healthcare (THC) stake by 129% in Q2 2026, buying an estimated $404K and bringing the position to 3,900 shares worth $730K. The position accounts for 0.02% of the portfolio, ranked #587.

Winton Group first reported a position in THC in Q4 2016 and has held it in 9 quarters since. The position peaked at $7.75M in Q3 2025. 677 funds tracked by Wall St. Rank hold THC as of Q2 2026.

Winton Group held 3,900 shares of Tenet Healthcare worth $730K as of Q2 2026.
Winton Group bought 2,200 Tenet Healthcare shares in Q2 2026, an estimated $404K.
Tenet Healthcare made up 0.02% of Winton Group's portfolio in Q2 2026, its #587 holding.
Winton Group first reported a position in Tenet Healthcare in Q4 2016 and has held it in 9 quarters since.
Winton Group's Tenet Healthcare position peaked at $7.75M in Q3 2025.
677 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.